[{"id": 1199756, "guidelineid": 100411, "drugid": "RxNorm:32968", "implications": {"CYP2C19": "Increased platelet inhibition; decreased residual platelet aggregation"}, "drugrecommendation": "Clopidogrel: label-recommended dosage and administration", "classification": "Strong", "phenotypes": {"CYP2C19": "Ultrarapid Metabolizer"}, "activityscore": {"CYP2C19": "n/a"}, "allelestatus": {}, "lookupkey": {"CYP2C19": "Ultrarapid Metabolizer"}, "population": "general", "comments": "The CYP2C19*17 allele may be associated with increased bleeding risks.", "version": 1, "drug": {"name": "clopidogrel"}, "guideline": {"name": "CYP2C19 and Clopidogrel"}}, {"id": 1199757, "guidelineid": 100411, "drugid": "RxNorm:32968", "implications": {"CYP2C19": "Increased platelet inhibition; decreased residual platelet aggregation"}, "drugrecommendation": "Clopidogrel: label-recommended dosage and administration", "classification": "Strong", "phenotypes": {"CYP2C19": "Rapid Metabolizer"}, "activityscore": {"CYP2C19": "n/a"}, "allelestatus": {}, "lookupkey": {"CYP2C19": "Rapid Metabolizer"}, "population": "general", "comments": "The CYP2C19*17 allele may be associated with increased bleeding risks.", "version": 1, "drug": {"name": "clopidogrel"}, "guideline": {"name": "CYP2C19 and Clopidogrel"}}, {"id": 1199758, "guidelineid": 100411, "drugid": "RxNorm:32968", "implications": {"CYP2C19": "Normal platelet inhibition; normal residual platelet aggregation"}, "drugrecommendation": "Clopidogrel: label-recommended dosage and administration", "classification": "Strong", "phenotypes": {"CYP2C19": "Normal Metabolizer"}, "activityscore": {"CYP2C19": "n/a"}, "allelestatus": {}, "lookupkey": {"CYP2C19": "Normal Metabolizer"}, "population": "general", "comments": "n/a", "version": 1, "drug": {"name": "clopidogrel"}, "guideline": {"name": "CYP2C19 and Clopidogrel"}}, {"id": 1199759, "guidelineid": 100411, "drugid": "RxNorm:32968", "implications": {"CYP2C19": "Reduced platelet inhibition; increased residual platelet aggregation; increased risk for adverse cardiovascular events"}, "drugrecommendation": "Alternative antiplatelet therapy (if no contraindication); e.g., prasugrel, ticagrelor", "classification": "Moderate", "phenotypes": {"CYP2C19": "Likely Intermediate Metabolizer"}, "activityscore": {"CYP2C19": "n/a"}, "allelestatus": {}, "lookupkey": {"CYP2C19": "Likely Intermediate Metabolizer"}, "population": "general", "comments": "n/a", "version": 1, "drug": {"name": "clopidogrel"}, "guideline": {"name": "CYP2C19 and Clopidogrel"}}, {"id": 1199760, "guidelineid": 100411, "drugid": "RxNorm:32968", "implications": {"CYP2C19": "Reduced platelet inhibition; increased residual platelet aggregation; increased risk for adverse cardiovascular events"}, "drugrecommendation": "Alternative antiplatelet therapy (if no contraindication); e.g., prasugrel, ticagrelor", "classification": "Moderate", "phenotypes": {"CYP2C19": "Intermediate Metabolizer"}, "activityscore": {"CYP2C19": "n/a"}, "allelestatus": {}, "lookupkey": {"CYP2C19": "Intermediate Metabolizer"}, "population": "general", "comments": "n/a", "version": 1, "drug": {"name": "clopidogrel"}, "guideline": {"name": "CYP2C19 and Clopidogrel"}}, {"id": 1199761, "guidelineid": 100411, "drugid": "RxNorm:32968", "implications": {"CYP2C19": "Significantly reduced platelet inhibition; increased residual platelet aggregation; increased risk for adverse cardiovascular events"}, "drugrecommendation": "Alternative antiplatelet therapy (if no contraindication); e.g., prasugrel, ticagrelor", "classification": "Strong", "phenotypes": {"CYP2C19": "Likely Poor Metabolizer"}, "activityscore": {"CYP2C19": "n/a"}, "allelestatus": {}, "lookupkey": {"CYP2C19": "Likely Poor Metabolizer"}, "population": "general", "comments": "n/a", "version": 1, "drug": {"name": "clopidogrel"}, "guideline": {"name": "CYP2C19 and Clopidogrel"}}, {"id": 1199762, "guidelineid": 100411, "drugid": "RxNorm:32968", "implications": {"CYP2C19": "Significantly reduced platelet inhibition; increased residual platelet aggregation; increased risk for adverse cardiovascular events"}, "drugrecommendation": "Alternative antiplatelet therapy (if no contraindication); e.g., prasugrel, ticagrelor", "classification": "Strong", "phenotypes": {"CYP2C19": "Poor Metabolizer"}, "activityscore": {"CYP2C19": "n/a"}, "allelestatus": {}, "lookupkey": {"CYP2C19": "Poor Metabolizer"}, "population": "general", "comments": "n/a", "version": 1, "drug": {"name": "clopidogrel"}, "guideline": {"name": "CYP2C19 and Clopidogrel"}}, {"id": 1199763, "guidelineid": 100411, "drugid": "RxNorm:32968", "implications": {"CYP2C19": "n/a"}, "drugrecommendation": "No recommendation", "classification": "No Recommendation", "phenotypes": {"CYP2C19": "Indeterminate"}, "activityscore": {"CYP2C19": "n/a"}, "allelestatus": {}, "lookupkey": {"CYP2C19": "Indeterminate"}, "population": "general", "comments": "n/a", "version": 1, "drug": {"name": "clopidogrel"}, "guideline": {"name": "CYP2C19 and Clopidogrel"}}]